MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer P Ji, S Diederichs, W Wang, S Böing, R Metzger, PM Schneider, N Tidow, ... Oncogene 22 (39), 8031-8041, 2003 | 2516 | 2003 |
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia T Schenk, WC Chen, S Göllner, L Howell, L Jin, K Hebestreit, HU Klein, ... Nature medicine 18 (4), 605-611, 2012 | 702 | 2012 |
The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth LH Schmidt, T Spieker, S Koschmieder, J Humberg, D Jungen, E Bulk, ... Journal of thoracic oncology 6 (12), 1984-1992, 2011 | 665 | 2011 |
International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, ... Biology of Blood and Marrow Transplantation 22 (1), 4-10, 2016 | 639 | 2016 |
Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival A Hamilton, GV Helgason, M Schemionek, B Zhang, S Myssina, EK Allan, ... Blood, The Journal of the American Society of Hematology 119 (6), 1501-1510, 2012 | 487 | 2012 |
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2 … C Röllig, H Serve, A Hüttmann, R Noppeney, C Müller-Tidow, U Krug, ... The lancet oncology 16 (16), 1691-1699, 2015 | 449 | 2015 |
Inherited and somatic defects in DDX41 in myeloid neoplasms C Polprasert, I Schulze, MA Sekeres, H Makishima, B Przychodzen, ... Cancer cell 27 (5), 658-670, 2015 | 439 | 2015 |
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group T Büchner, WE Berdel, C Haferlach, T Haferlach, S Schnittger, ... Journal of clinical oncology 27 (1), 61-69, 2009 | 421 | 2009 |
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial H Serve, U Krug, R Wagner, MC Sauerland, A Heinecke, U Brunnberg, ... Journal of Clinical Oncology 31 (25), 3110-3118, 2013 | 383 | 2013 |
Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells C Müller-Tidow, B Steffen, T Cauvet, L Tickenbrock, P Ji, S Diederichs, ... Molecular and cellular biology 24 (7), 2890-2904, 2004 | 379 | 2004 |
Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes C Choudhary, JV Olsen, C Brandts, J Cox, PNG Reddy, FD Böhmer, ... Molecular cell 36 (2), 326-339, 2009 | 367 | 2009 |
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation GHS Richter, S Plehm, A Fasan, S Rössler, R Unland, IM Bennani-Baiti, ... Proceedings of the National Academy of Sciences 106 (13), 5324-5329, 2009 | 359 | 2009 |
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations M Mizuki, J Schwäble, C Steur, C Choudhary, S Agrawal, B Sargin, ... Blood, The Journal of the American Society of Hematology 101 (8), 3164-3173, 2003 | 359 | 2003 |
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes U Krug, C Röllig, A Koschmieder, A Heinecke, MC Sauerland, M Schaich, ... The Lancet 376 (9757), 2000-2008, 2010 | 348 | 2010 |
Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia JA Pulikkan, V Dengler, PS Peramangalam, AA Peer Zada, ... Blood, The Journal of the American Society of Hematology 115 (9), 1768-1778, 2010 | 342 | 2010 |
Apolipoprotein E induces antiinflammatory phenotype in macrophages D Baitsch, HH Bock, T Engel, R Telgmann, C Müller-Tidow, G Varga, ... Arteriosclerosis, thrombosis, and vascular biology 31 (5), 1160-1168, 2011 | 338 | 2011 |
AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations C Choudhary, J Schwäble, C Brandts, L Tickenbrock, B Sargin, ... Blood 106 (1), 265-273, 2005 | 325 | 2005 |
Side-effect management of chimeric antigen receptor (CAR) T-cell therapy ML Schubert, M Schmitt, L Wang, CA Ramos, K Jordan, C Müller-Tidow, ... Annals of oncology 32 (1), 34-48, 2021 | 318 | 2021 |
The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia B Linggi, C Müller-Tidow, L Van De Locht, M Hu, J Nip, H Serve, ... Nature medicine 8 (7), 743-750, 2002 | 311 | 2002 |
Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation CH Brandts, B Sargin, M Rode, C Biermann, B Lindtner, J Schwäble, ... Cancer research 65 (21), 9643-9650, 2005 | 291 | 2005 |